AlzeCure Pharma AB (publ) (STO:ALZCUR)
Sweden · Delayed Price · Currency is SEK 8.08
+0.14 (1.76%)
Sep 2, 2026, 5:29 PM CET
AlzeCure Pharma AB Market Cap
AlzeCure Pharma AB has a market cap or net worth of 1.09 billion as of September 2, 2026. Its market cap has increased by 157.51% in one year.
Market Cap
1.09B
Enterprise Value
1.08B
Revenue
97.33M
Ranking
n/a
PE Ratio
29.42
Stock Price
8.08
ChartMarket Cap Chart
Since November 28, 2018, AlzeCure Pharma AB's market cap has increased from 415.42M to 1.09B, an increase of 163.56%. That is a compound annual growth rate of 13.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2026 | 1.09B | 376.40% |
| Dec 30, 2025 | 229.83M | 126.34% |
| Dec 30, 2024 | 101.54M | -47.41% |
| Dec 29, 2023 | 193.09M | -24.88% |
| Dec 30, 2022 | 257.04M | 14.39% |
| Dec 30, 2021 | 224.71M | -34.33% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 28, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Saniona AB | 1.63B |
| BioInvent International AB | 1.52B |
| Flerie AB | 1.48B |
| Genovis AB (publ.) | 1.44B |
| Medivir AB | 1.22B |
| SynAct Pharma AB | 1.15B |
| Infant Bacterial Therapeutics AB | 847.35M |
| Oncopeptides AB | 739.19M |